SNRPFP2

Across TCGA pan-cancer cohorts, SNRPFP2 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SNRPFP2’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where SNRPFP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNRPFP2 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

LUSC, BLCA, and LUAD are the cancer types where SNRPFP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNRPFP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	+0.351	<.001	4	view →
BLCA	All	All	+0.326	.014	4	view →
LUAD	All	II,III,IV	+0.283	.003	4	view →
UCEC	All	IV	+0.515	.032	2	view →
KIRC	All	IV	−0.080	.013	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

SNRPFP2–LUSC

Open the LUSC breakdown →